Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15631667rdf:typepubmed:Citationlld:pubmed
pubmed-article:15631667lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:15631667lifeskim:mentionsumls-concept:C2004454lld:lifeskim
pubmed-article:15631667lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:15631667lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:15631667lifeskim:mentionsumls-concept:C1705576lld:lifeskim
pubmed-article:15631667lifeskim:mentionsumls-concept:C1515895lld:lifeskim
pubmed-article:15631667pubmed:issue6lld:pubmed
pubmed-article:15631667pubmed:dateCreated2005-1-5lld:pubmed
pubmed-article:15631667pubmed:abstractTextThis study was aimed to investigate various factors influening erythrocyte recovery following ABO-incompatible allogeneic HSCT. 157 patients following ABO-incompatible allogeneic HSCT were selected for the investigation. Cox regression analysis were used to identify the statistically significant factors including sex, age, schemes of transplantation, HLA-matched, mismathed, conditioning regimens, preventive measures for GVHD, occurrence of grade I-II GVHD, CMV infections and types of incompatible blood group. The results showed that minor ABO-incompatible, number of mononuclear cells infused, age of patients and unrelated BMT were four important main factors influening the erythrocyte recovery. In conclusion, the erythrocyte recovery is more quick in patients with minor ABO-incompatible and more number of mononuclear cells infused, while it is slow in patents with old age and unrelated BMT.lld:pubmed
pubmed-article:15631667pubmed:languagechilld:pubmed
pubmed-article:15631667pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15631667pubmed:citationSubsetIMlld:pubmed
pubmed-article:15631667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15631667pubmed:statusMEDLINElld:pubmed
pubmed-article:15631667pubmed:monthDeclld:pubmed
pubmed-article:15631667pubmed:issn1009-2137lld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:VosJ JJJlld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:QianJiangJlld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:LuDao-PeiDPlld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:LiuKai-YanKYlld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:HuangXiao-Jun...lld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:BaoLiLlld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:ChenYu-HongYHlld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:XuLan-PingLPlld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:ZhangYao-Chen...lld:pubmed
pubmed-article:15631667pubmed:authorpubmed-author:LiuDai-HongDHlld:pubmed
pubmed-article:15631667pubmed:issnTypePrintlld:pubmed
pubmed-article:15631667pubmed:volume12lld:pubmed
pubmed-article:15631667pubmed:ownerNLMlld:pubmed
pubmed-article:15631667pubmed:authorsCompleteYlld:pubmed
pubmed-article:15631667pubmed:pagination812-5lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:meshHeadingpubmed-meshheading:15631667...lld:pubmed
pubmed-article:15631667pubmed:year2004lld:pubmed
pubmed-article:15631667pubmed:articleTitle[Multiple factors in erythrocytic recovery following ABO-incompatible allogeneic HSCT].lld:pubmed
pubmed-article:15631667pubmed:affiliationInstitute of Hematology, People Hospital, Peking University, Beijing 100044, China.lld:pubmed
pubmed-article:15631667pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15631667pubmed:publicationTypeEnglish Abstractlld:pubmed